Method for measurement of the size of the HIV cell reservoir and for its determination in patients who are not experienced with ART
- Authors: Kvasov N.A.1, Polyakova A.K.1, Lopatukhin A.E.1, Murzakova A.V.1, Shemshura A.B.2, Kireev D.E.1
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Cinical Center for AIDS Prevention and Control, Ministry of Health of the Krasnodar Territory
- Issue: Vol 11, No 4 (2021)
- Pages: 66-72
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287835
- DOI: https://doi.org/10.18565/epidem.2021.11.4.66-72
- ID: 287835
Cite item
Abstract
Full Text
About the authors
Nikita A. Kvasov
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: kvasov.bio@gmail.com
Junior Researcher
Angelina K. Polyakova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: angelina.polya@gmail.com
Junior Researcher
Alexey E. Lopatukhin
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: a.lopatukhin@gmail.com
Researcher
Anastasia V. Murzakova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: murzakova_a.v@mail.ru
Researcher
Andrey B. Shemshura
Cinical Center for AIDS Prevention and Control, Ministry of Health of the Krasnodar Territory
Email: shemsh@mail.ru
Cand. Med. Sci., Clinical Laboratory Diagnostician
Dmitry E. Kireev
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-BeingCand. Biol. Sci., Head, Laboratory of Diagnostics and Molecular Epidemiology of HIV Infection
References
- Deeks S.G., Lewin S.R., Havlir D.V. The end ofAIDS: HIV infection as a chronic disease. The Lancet 2013; 382(9903), 1525-33. https://doi.org/10.1016/S0140-6736(13)61809-7
- Турсунов Р.А., Канесдри В.Г., Симонова Е.Г., Раичич Р.7. Антиретровирусная терапия-новая эпоха профилактики ВИЧ-инфекции. ВИЧ-инфекция и иммуносупрессии 2018; 10(1): 37-46. https://doi.org/10.22328/2077-9828-2018-10-1-37-46
- Barton K., Winckelmann A., Palmer S. HIV-1 reservoirs during suppressive therapy. Trends in Microbiology 2016; 24(5), 345-15. https://doi.org010.W16rj.tim.2016.01.006
- Abdel-Mohsen M., Richman D., riliciano R.F., Nusse/zweig M.C., Howell B.J., Martinez-Picado J., Montaner L.J. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Medicine 2020; 26(9): 1339-50. https://doi.org/10.1038/s41V91-020-1022-1
- Kiselinova M., De Spiegelaerr Wr Buzon M.J., Malatinkova E.d LichterVeld I'M., Vandekerckhove L. Integrated and total HIV-1 DNA predict ex vivo viral outgrowth. PLoS Pathogens 2016; 12(3); е1005472. https://doi.org/10.1371/journal.ppat.1005472
- Tsiara C.G., Nikolopoulos G.K., Bagos P. G., Goujard C., Katzenstein T.L., Minga A.K. , Hatzakis A. Impact of HIV type l DNA levels on spontaneoos diaease progression: a meta-analysis. AIDS Research and Human Retroviruses 2012; 28(4): 366-73. httpsTdoi.org/10.1089/aid. 2011.0032
- Shiramizu 13., Paul IP., Williams A., Shikuma C., Watters М., Grove J., Valcour V. HIV proviral DNA associated with decreased neuropsychological function. J. Neuropsychiatry Clin. Neurosci. 2007; 1-9(2): 157-63. https://doi.org/10.1176/jnp.2007.19.2.157
- Parisi S.G., Andreis S., Mengoli C., Scaggiante R., Ferretto R., Manfrin V., Sarmati L. Baseline cellular HIV DNA lo ad predicts HIV DNA decline and residual HIVplasma levels during effective antiretroviral therapy. J. Clin. Microbiol. 2012; 50(2): 258-63. https://doi.org/10.1128/JCM.06022-11
- Rouzioux C., Hubert J.B., Burgard М., Deveau C., Goujard С., Вагу М., Meyer L. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J. Infectious Diseases 2005; 192(1), 46-55. https://doi.org/10.1086/430610
- Бобкова M.R Стратегии излечения ВИЧ-инфекции: основные методологические подходы и проблемы их реализации. ВИЧ-инфекция и иммуносупрессии 2020; 12(1): 22-31. https://doi.org/10.22328/2077-9828-2020-12-l-22-31
- Wong J. K., Hezareh М., Gunthard H. F., Havlir D.V., Ignacio C.C., Spina C.A., Richman D.D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278(5341): 1291-5. https://doi.org/10.1126/science.278.5341.1291
- Butler S.L., Hansen M.S., Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nature Medicine 2001; 7(5): 631-4. https://doi.org/10.1038/87979
- Bruner K. M., "Wang Z., Simonetti F.R., BenderA.M. , Kwon K.J., Sengupta S., Siliciano R.F.A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 2019: 566(7742): 120-5. https://doi.org/10.1038/s41586-019-0898-8
- Gaebler C., Lorenzi J.C., Oliveira T.Y., Nogueira L., Ramos V., Lu C. L., Nussenzweig M.C. Quadruplex qPCR for qualitative and quantitative analysis of the HIV-1 latent reservoir. bioRxiv 2019; 641951. https://doi.org/10.1101/641951
- Веселова Е.И., Каминский Г.Д., Самойлова А.Г., Васильева И.А. (2019). Резервуар ВИЧ у больных ВИЧ-инфекцией. Туберкулез и болезни легких 2019; 97(5): 50-7. https://doi.org/10.21292/2075-1230-2019-97-5-50-57
- Rouzioux C., Avettand-Fenoel V. Total HIV DNA: a global marker of HIV persistence. Retrovirology 2018; 15(1): 1-7. https://doi.org/10.1186/sl2977-018-0412-7
- Wang Z., Simonetti F.R., Siliciano R.F., Laird G.M. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir. Retrovirology 2018; 15(1): 1-9. https://doi.org/10.1186/s12977-018-0404-7
- Imamichi H., Dewar R.L., Adelsberger J.W., Rehm C.A., O’Doherty U., Paxinos E., Lane H.C. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proceedings of the National Academy of Sciences 2016; 113(31): 8783-8. https://doi.org/10.1073/pnas.1609057113
- Pham H.T., Mespl Me T. The latest evidence for possible HIV-1 curative strategies. Drugs in Context 2018; (7). doi: 10.7573/dic.212522
- Sengupta S., Siliciano R.F. Targeting the latent reservoir for HIV-1. Immunity 2018; 48(5): 872-95. https://doi.org/10.1016/j.immuni.2018.04.030
- Saitoh A., Hsia K., Fenton T., Powell C.A., Christopherson C., Fletcher C.V., Spector S.A. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. J. Infect. Dis. 2002; 185(10): 1409-16. https://doi.org/10.1086/340614
- Hoen B., Cooper D.A., Lampe F.C., Perrin L., Clumeck N., Phillips A. N., QUEST Study Group. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PR0B3005. Clin. Infect. Dis. 2007; 45(3): 381-90. https://doi.org/10.1086/519428
- Ngo-Giang-Huong N., Deveau C., Da Silva I., Pellegrin I., Venet A., Harzic M., French PRIMO Cohort Study Group. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy. AIDS 2001; 15(6): 665-73.
- Tsiara C.G., Nikolopoulos G.K., Bagos P. G., Goujard C., Katzenstein T.L., Minga A.K., Hatzakis A. Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis. AIDS Research and Human Retroviruses 2012; 28(4): 366-73. https://doi.org/10.1089/aid.2011.0032
- Goujard C., Bonarek M., Meyer L., Bonnet F., Chaix M.L., Deveau C., Agence Nationale de Recherche sur le Sida PRIMO Study Group. CD4+ cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin. Infect. Dis. 2006; 42(5): 709-15. https://doi.org/10.1086/500213